Atrandi Biosciences
Atrandi Biosciences is breaking new ground in high-throughput analysis technologies.
Vilnius, Lithuaniawww.atrandi.com ↗
Total raised
€24M
€23,966,263
Funding rounds
1
Investors
5
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-19 | Series A | €24M | GRIDS Capital,Lux Capital,Metaplanet,Practica Capital,Vsquared Ventures | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Vinted€822MLithuania · Fashion
- Oura Health€779MFinland · Healthtech